Warrington, PA, United States of America

Steven H Spergel

This inventor holds 40 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Bristol-Myers Squibb Compnay, E. R. Squibb Sons, Inc., Bristol Meyers Squibb Company. Active years: 1993-2025.

USPTO Granted Patents = 40 (Patent Applications = 12)

% Patents Active = 97.5

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 5.0

ph-index = 11

Forward Citations = 333(Granted Patents)

Location History:

Bensalem, PA (US) (1993 - 1996)
Warrington, PA (US) (1998 - 2024)

Company Filing History:

37 out of 3,737

Bristol-Myers Squibb Compnay

patents

2 out of 1,624

E. R. Squibb Sons, Inc.

patents

1 out of 41

Bristol Meyers Squibb Company

patents

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Kinase Inhibitors

IL-12 Modulators

Inflammatory Diseases

Autoimmune Diseases

Nuclear Hormone Receptors

Thiazolyl Inhibitors

Aminoimidazopyridazines

Imidazoquinoxaline

Aminotriazolopyridines

Pyrrolopyridazine

Substituted Isoxazole

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240840 - Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha (2025-03-04),

2. 12157733 - Aminotriazolopyridines as kinase inhibitors (2024-12-03),

3. 12110290 - Triazolopyridinyl compounds as kinase inhibitors (2024-10-08),

4. 11884650 - Substituted heterocyclic compounds (2024-01-30),

5. 11866414 - Substituted heterocyclic compounds (2024-01-09),

6. 11767322 - Triazolopyridinyl compounds as kinase inhibitors (2023-09-26),

7. 11440913 - Aminoimidazopyridazines as kinase inhibitors (2022-09-13),

8. 11299494 - Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators (2022-04-12),

9. 10913738 - Aminotriazolopyridines as kinase inhibitors (2021-02-09),

10. 10836770 - Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses (2020-11-17),

11. RE47929 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses (2020-04-06),

12. 10000480 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses (2018-06-19),

13. 9505748 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses (2016-11-29),

14. 9221826 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases (2015-12-29),

15. 8987268 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases (2015-03-24),

Title: The Innovative Journey of Steven H Spergel

Introduction: Steven H Spergel, a talented inventor hailing from Warrington, PA (US), has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Steven H Spergel holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: Throughout his illustrious career, Steven H Spergel has been recognized for his innovative thinking and problem-solving skills. He has received numerous awards for his contributions to the tech industry.

Collaborations: Steven H Spergel has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work in diverse teams has led to the successful development of cutting-edge technologies.

Conclusion: Steven H Spergel's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors and innovators.